English Subtitles for 5. Molecular Genetics II



Subtitles / Closed Captions - English

Stanford University. Let's see. Various announcements. I am out of town tomorrow, so no office hours. I managed effortlessly to confuse a whole bunch of people

Monday about positive selection versus stabilizing selection. All of that on the Q&A part of the course works. I've pulled out the paragraphs from the extended readings that explain that coherently, as opposed to what happened here. And Monday-- Monday I discovered that somebody sitting in this room, who I cannot spot at the moment,

has a spectacular tattoo illustrating the central dogma of life, or at least one person. If there's two, it's really something. So amazing demonstration of DNA to RNA to protein. So if the person doesn't have a class afterward, he will be standing up on top of this counter

here displaying it for everybody's educational purposes. So besides finding about that guy, what else happened Monday? Monday we introduced two concepts and, with great dramatic foreshadowing, started to trash both.

The first one being this huge emphasis in all of the preceding lectures on the evolution of behavior-- not only this emphasis on adaptation, not only this emphasis on inferring a genetic basis through that roundabout-- here's a story and until you make up a better one, I win.

But also that emphasis on gradualism, that slow evolutionary change. What we focused on there was what would be the mechanisms, the molecular mechanisms, for classic gradualist evolutionary change, microevolution, the whole world of point mutations-- deletion,

insertion, all of that, the whole world of mutations potentially being big news, knocking a protein completely out of business and suddenly you've got a different gender than you actually are chromosomally, but a world, none the less, where for our soundbite, micromutations are affecting how readily a protein does

its job-- how strongly, how potently, how long, what its job is, all of that, that as sort of the grist for the microevolutionary change. What we then transitioned to was the huge, huge attack on the gradualism that came with this view of punctuated equilibrium, this notion

that most of the time, nothing exciting was happening, long periods of stasis, and then sudden, dramatic change proposed by Gould, other evolutionary people. And what we saw was the huge implication. There it was. If most of the time, nothing interesting

is happening in terms of evolutionary shift, there goes gradualism, there goes the emphasis of every bit of adaptation is going to make a difference long term, every, opportunity to compete, compete and dominate, is going to make a difference.

All of that goes down the drain if 99% of the time, there is instead equilibrium stasis. What we saw were the wildly enthused attacks upon it along the grounds of that stasis and rapid change for paleontologists bears no resemblance to what the world is like for an evolutionary biologist.

Paleontologists can only see the evolution of boring stuff-- morphology. You miss the entire world of what's going on inside that morphology. And the most damning sort of complaint, show me some molecular mechanisms

for these macroevolutionary changes. What we then transitioned to was seeing all the ways in which the picture of the structure of genes and DNA is completely wrong along the lines of there's the intervening sequences, the intron/exon organization of genes.

Suddenly the opportunity to mix and match combinatorial abilities for one gene, or at least one stretch of DNA, to specify a whole bunch of different proteins, depending on the function of the splicing enzymes, and those splicing enzymes differing in different parts of the body

under different circumstances. We then saw that flabbergasting business about 95% of DNA not coding for proteins, not being genes, but instead, the instruction manuals, the promoters, the switching on and off, leading to that critical notion of transcription factors transducing events going on

out there, out there outside the nucleus, outside the cell, outside the organism, into changes in DNA, and thus the incredibly important role of transcription factors, promoters. There are a lock and key interactions. All that sorts of stuff introducing

the second critical concept-- if microevolution is about sort of changing the function of a protein, changes occurring at the level of transcription factors or promoters, those are about changing the context for which proteins are functioning when genes are expressing.

What they are about are introducing if/then clauses. If this is happening outside the nucleus, cell, universe, whatever, then if that results in this gene being activated, then you will see that response. What came along sort of de facto with that, the second major thing that we thus trashed,

was DNA as the central starting point, the dogma of life. DNA is the only one who knows what's going on out there. DNA commands, RNA commands, protein commands all of life. And what we saw was DNA, genes, are just a readout and most of what it's about is environmental regulation of when genes activate.

Finally we began to see all sorts of ways of futzing around with gene expression that has nothing to do with the sequences of DNA, but instead has to do with things like access of transcription factors to the DNA, changing accessibility permanently, that whole world of epistatic, epigenetic changes,

coming up with that sound soundbite. Fertilization is about genetics. Development is about epigenetics-- all of that combining to show, number one, genes are not such a hot deal in terms of them knowing what's up. Number two, in addition to mechanisms

known for microevolutionary change, we left just on the cusp of seeing how all of this stuff can set you up for some big time macroevolutionary changes. First example of it. First way in which that could occur. So back to the modular construction of genes.

We've got our introns, exons, all of that. And what we learned the other day is here we've got a gene coded for with three exons. You produce a messenger RNA that encompasses all of these plus the introns. Along comes a specific splicing enzyme, knocks out these parts,

and here is the mature protein. So that's great. What if you have a mutation in your splicing factor, in your splicing enzyme, and as a result, instead of clipping here, it ignores those and clips here instead.

What do you get? You get two completely novel proteins that never existed before in this cell, in this individual. What you've got there is not some sort of little microevolutionary change. This is not a protein working a little bit better

or a little bit more sluggish. This is the invention of entirely new proteins. So what we see here is splicing factors working differently. And this is a major change, if whatever went on in the outside world that causes the then of this being made, if you've got that mutation in the splicing

factor, you've just made entirely new if/then. If whatever's going on in the outside world happens to activate this, you produce these two novel proteins. So we've suddenly got the potential for producing all sorts of novelty.

They're splicing enzymes, enzymes, proteins, thus there are genes coding for the splicing enzymes. As a result, suddenly a very different type of consequence. Yeah, question? How often do those [INAUDIBLE] make it out of the [INAUDIBLE]? Great question.

How often do they make their way out of the-- [INAUDIBLE] What was that? How often do the mis-splice [INAUDIBLE] successfully have function? Do they have any function?

[INAUDIBLE] That's a critical question. Wait about an hour and 17 minutes and you will get the answer to it-- the answer being, not very often. Oops.

I gave it away. The answer being not very often. And we're going to see why that's real critical to punctuated equilibrium. So we see one realm of major consequence. And intrinsic in that is, wait a second-- so if splicing

enzymes, enzymes are genes. There's a gene for the splicing enzyme. And that gene has its promoters. And that gene maybe is in a number of exons. And thus it needs a splicing factor. And we're rolling all the way down there.

Recursive regulation. So one splicing factor, big consequence. Next realm where you can have a big consequence is now you've got a mutation in a promoter. A whole world of a mutation in a noncoding part of your DNA. And you can immediately run with that one.

Have a different promoter, and it's going to interact with a different transcription factor. And we go back to that business about typically a promoter, the same version of it, multiple copies of that promoter, appear upstream of various different genes-- promoters mediating expression of entire network of proteins.

Change that promoter and you're going to change the network. Change that promoter in only some of the places where it occurs and now you've created a completely novel network, a network consisting maybe of half of the proteins that you would have made in the unmutated version.

Mutate every single version of it, and maybe it's an entirely different transcription factor that interacts with that promoter. And thus we've made an entirely new if/then clause-- not just a new if/then make a never seen before protein. Now it's an if this happens, then make

a network of proteins that have never existed before, a combination of these that have never occurred before. What we're beginning to see here is a theme of amplifying affects. Huge, major consequences, instead of one little protein which, thanks to one little base pair

changing, is 1 and 1/2 degrees more folded this way instead of that way and 1.5% better at binding this or that hormone. That's the microevolutionary this is setting up for big network changes. Novel genes, novel networks, novel if/then clauses.

Third range-- an example of why promoters and promoter mutations are interesting. Later on in the course, we are going to hear about one of the all time interesting differences that you can have in one of your promoters if you happen to be a vole and, increasingly it's turning out,

equally interesting if you happen to be a human. This is a promoter upstream of a gene having to do with the hormone vasopressin. Do not panic or care if you haven't heard of this yet. But you will have in more detail within a few weeks. Vasopressin is this hormone which has something

or other to do with social affiliated behavior in males and all sorts of interesting stuff with that. And naturally, it being a hormone, out there is a vasopressin receptor. And thus, there's a vasopressin receptor gene. And there's a promoter upstream of that gene

which turns out to come in a couple of different flavors. And you look at voles, which are a little hamster thingee sort of things. And there's all sorts of different vole species. And there's ones in the mountains, and there's ones in the plains, and there's

ones from California to the New York islands. And there's all these different species. And it happens some of them happened to be monogamous. Some of them happen to be polygamous. We're off and running with the social biology of that and how many imprinted genes and all that they're going to have.

But a critical difference in monogamous vole species-- there is a different promoter upstream of the vasopressin receptor gene than you find in the polygamist ones. And go and mess around with them, use gene therapy techniques to change the promoter

to modify it, and you could convert a polygamous male vole into a resoundingly monogamous one. And I don't know if this counts as gene therapy like curing a disease or just gene transfer sort of stuff, but what you've got here is change your promoter and you suddenly have a different pattern

of expression, which parts of the brain it winds up in. Suddenly you have made a major shift in behavior. You're not causing a change in a gene. You're causing a change in its promoter. You've just changed a major if/then clause. Another example of it-- there is a gene

that codes for hormone neurotransmitter that has something to do with pain perception called dynorphin. It's broadly related to things like morphine and such. It's got a dynorphin gene that's a little more complicated than that. But there's a promoter upstream.

And recent research is showing that the number of copies of that promoter in different rats predicts something about how readily they become addicted to various drugs. And that winds up being pertinent. Back for a second.

Back to the vasopressin gene and the vasopressin reporter gene and it's promoter. In the last couple of years, a number of studies come out. One, for example, in a very credible journal by a great group showing that if you happen to be a human male, which version of that promoter

you have gives you a certain significant predictive power over how stable your social relationships are going to be. Get a load of that one. And that one is coming later on. Whoa. Have a different type of promoter and statistically

you are more likely to get divorced down the line. Back to that first lecture freewill stuff. There is so much more to come along those lines. We will look at the vasopressin system much more in the sex lectures. But again, that's not a difference in a gene.

That's a difference in the promoter. Next domain-- we've now seen changes, subtle changes, dramatic changes, in splicing enzymes and the genes underlying them, changes in promoters. Next obvious domain where you can get a macro, macro change is a mutation in a gene for a transcription factor,

obviously. Do that and you're going to have completely different networks. Once again, you will have changed if/then contingencies dramatically. Transcription factors are very, very important, obviously. One measure of this-- when you look

at the human genome versus the chimp genome, and we will eventually do that in some detail and say, 98% of our genes in common, which is kind of accurate. And you remember from the other day how that's different. It's the level of explanation than you sharing 50% of your genes with your full sibling.

All of that. Back to us sharing 90%, 98% of our DNA with chimps. What are the differences? And there's going to be some really interesting differences we're going to focus on down the line. But one of the patterns that's come out

of that is a disproportionate share of the genetic differences between humans and chimps are genes that code for transcription factors. And that makes perfect sense. You get a change in some gene coding for some structural protein and maybe

your muscles will bend a little bit this way instead of that way, or who knows what. You get a change in the gene coding for transcription factor and you will have invented all sorts of novel networks. So a disproportionate share of what has gone on in evolution differentiating us from chimps

are changes in transcription factors. This was a big triumph, big support, for a view that came out in the '80s. There were a pair of scientists at Berkeley, King and Wilson, and this iconic set of studies they did. They were the first persons, people,

to come up with a 98% business there. And using very primitive molecular techniques that have since been affirmed-- and they also came up with a prediction, a purely theoretical one, which is, the most interesting changes that will occur in evolution are in regulatory parts of DNA rather than in the coding

parts for protein. And everything since then has supported that, including things like, you want to turn an ancestor of a human and a chimp into something that will look a whole lot different from a chimp, turn into us,

change stuff with regulation, transcription factors, promoters. What you see with that is this is endlessly networks for amplifying effects for macro changes. And there's a new person in the department, Bio department, Hunter Frazier, a new assistant professor,

who works in this area showing just how much evolutionary change is being driven by change in regulatory parts of the DNA world, rather than the genes itself. Changing a little bit about how this protein works, that's OK. Changing if/then clauses for entire networks,

that's hugely important. Another interesting factoid-- there's now been the genomes of, I don't know, about 100 different species sequenced, and ranging from really short genomes with I don't know how many genes in there, to the longest ones.

When you pile them up and you look at them as a function of how long their genomes are, the more genes you find in a species, the greater the percentage of those genes are that are transcription factors. And this makes wonderful sense as well.

You got one gene and you only need one transcription factor. You got two genes and you could milk maximal information out of them with three transcription factors. You transcribe A or B, or AB. You've got three genes and there's seven. And the equation is 2 to the nth.

This one. Whatever. But what you see is by four genes, you're up to 15. By five genes, you're up to 30-- you're having an exponential, a dramatic increase in the number of transcription factors you need to take advantage

of all the possible combinations of networks of gene expression. The larger the number of genes you find in an organism, the greater the percentage it is of transcription factors. In other words, get tiny little micro, micro changes in DNA coding for transcription factor splicing, enzymes, promoters, and you're going to have big major consequences.

So over and over here, we see this contrast microevolution is about the function of proteins. Macroevolution is about which proteins-- when networks' if/then clauses are far more consequential. One additional domain of-- we're not talking about a tiny little micro change

in one base pair-- one additional domain, a highly revolutionary one that came some years ago that also has lots of implications for thinking about macro stuff in evolution. And this revolved around one of the great irresistible musical dramas that have ever come out of the history of science.

Once that is-- there's got to be a musical somewhere in the future of this-- having to do with a scientist named Barbara McClintock. Barbara McClintock-- if you are sort of a modern molecular sort of person, at some point or other, you will have to have sacrificed a goat at the altar of Barbara

McClintock. She is so amazing and she has such a stirring story as to what happened with her, one which actually is so. Barbara McClintock was born, I don't know, about 1900 or so, and was a plant geneticist and was sort of off doing genetics of plants and doing something or other

with maize. Whatever those people do. And she was extremely successful. She was wildly successful. I think at age 40 or so in the late 1930s, she was already a member of what's

called the National Academy of Sciences, which is like the most honorific science club you can belong to in this country. 40-year-old women in 1940 were not becoming members of the National Academy of Sciences. 110-year-old white guys with shiny foreheads

were becoming members of the National Academy. For her to have been elected at that point, she was an amazing scientist, one of the absolute leaders in the field. So she's cruising along there, being renowned. And one day she made a discovery that completely

destroyed her career. So she's sitting there one day and she studies beloved corn maize and the patterns of inheritance based on colors of kernels. Genes, molecular biology, like nonexistent. None of the stuff available now.

All you could do in terms of making sense of what is being inherited, patterns of inheritance, is just looking at the phenotype, looking at the appearance. Peas and whether they're wrinkly or not, people and whether they're wrinkly or not, corn

and what the colors are of the various kernels there. That was cutting edge molecular sort of genetics at the time. So she's working in that domain and she's seeing a result. She's seeing a pattern of inheritance which keeps popping up in certain circumstances. And you go through all of the inferential math that

was available and you crunch through everything. And you, if you were Barbara McClintock pursuing this, you come up with a conclusion that is totally nutty. The only way to explain how this change was occurring was if genes were picking up and moving around on the DNA, if gene were jumping around, if genes were mobile,

moving around. And out of this, she came up with a proposal that there are such things as transposable genes, transposable genetic elements, transposons. All of the people who spent decades afterward mocking her in various ridiculing tones of voices

soon referred to these as jumping genes. And the general consensus in the field was that Barbara McClintock had gone out of her mind. Yeah, genes jumping around. Yeah, right. I'll sell you the Brooklyn Bridge

after that if you believe it. That's ridiculous. That's ridiculous. And Barbara McClintock, having a certain stoic self-esteem sort of based personality of one that was-- basically said, you know what?

This is what I see. You want to believe it, believe it. You don't want to believe it, don't believe it. Leave me alone, I want to go back to my experiments. And she essentially disappeared from the field and just sat out in her cornfield

at a lab in Long Island called Cold Spring Harbor lab, and just chugged along on her own for decades afterward. She wrote papers about it that were incomprehensible to people, because no one could believe anything this ridiculous. And she was developing this whole story

about genes that move, transposable genetic elements. Everybody ignored her. She was mocked. She was pilloried. She was burned at the stake. All of that.

And then finally somewhere in the 1980s, molecular techniques caught up enough to show she was absolutely right. And these things now are called transposons. Transposable genetic elements. Genes really do pick up and move around. And this was an amazing landmark discovery.

The entire world went crazy about Barbara McClintock at the time. She was on the cover of Post's Wheaties boxes of cereal. [LAUGHTER] There were Barbara McClintock lines of dance clothes and exercise videos and recipe books

and all of that. And somewhere along the way, they gave her her Nobel Prize. And she was in her late 80s at the time. And showing exactly the stuff she was made out of, she said, well, that's nice. Thanks for the Nobel Prize.

But you know what? I didn't really need to have gotten it. This is what I saw. You want to believe it, yes or no? You believe it now? That's nice.

Leave me alone. Let me go back to work. [LAUGHTER] And she continued to work in her cornfields doing experiments up until about a week before her death in the early '90s. This is a totally cool, amazing figure

in the history of science, a lonely pioneer. As it turned out, she wasn't that lonely of a pioneer and people didn't think she was quite that crazy. And apparently a lot of her papers were ignored because she could not write and her papers were incomprehensible.

But nonetheless, the general picture was, she discovered all of this on her own, staked her career on this, and most people thought she was out of her mind and eventually vindicated. Totally cool sort of piece of the history of science. Really, really inspirational person.

And I met her once and got to see her with her corn and she was-- [LAUGHTER] A remarkable-- she was like 90 at the time-- and a remarkably nice, low-key person, where after about 13 and a half seconds, it was obvious that what she mostly wanted

was for me to get the hell out of there so she could go back to her corn, which was her response to everybody there. But very heroic figure. So she discovers this entire new world of these transposable genetic elements.

And people have been studying it since, these jumping genes. The first thing that has become clear as the field ha matured is she picked the right species to study. She never would have discovered transposable genetic elements if she was out there alone in her cornfield

studying sperm whales or something. Separate of the funding problems and the logistics, she would not have found it. She did it in the right organisms, which were plants. Think about it. You are an animal.

And one of the things you can do is, when the going gets tough, you can get up and run away, or you can crawl away or fly away or whatever sort of animate animal type things can do. If you're a plant, you're stuck there. You can't run away. And if you're going to survive a challenge,

you're going to have to have something more subtle going for you than, oh, let's run and get out of here. And it turns out all sorts of realms of plant stress responses are in just the avant garde of molecular biology. Plants have to have fancier tricks

than all sorts of boring animals because plants don't run away. What they do instead, among their various defenses, when a challenge, a pathogen, a climate change, whatever it is comes along, one of the things they do is there's realms of their DNA where they move genes around, where they shuffle stuff around in the hopes of stumbling

onto something novel and useful to get them out of that mess. Plants have induce-able events of genes moving transposable genetic elements. They tend to induce them when the plant is under some sort of challenge, a cellular stress response. And the way that's done is by activating

an enzyme called transposase. And those of you who are new to the business, enzymes tend to have -ase the end of the word-- lactase, sucrase, transposase. And what you've got there is, this is a defense on the part of the plant.

Juggle some of its DNA prudently, and see if you can come up with something to help you. Make a copy of the gene, and then go plunk it down somewhere else and see if you've stumbled into something useful. And it was only in the aftermath that people

started to look at the same issue in animals and vertebrates and mammals. And shockingly to everyone, except the people who hung out with her, was the fact that we've got them, too. We've got transposable genetic elements, we animals. We've got them.

Where they were first discovered made a lot of sense as well. You are some scientists and you've just invented in your lab some pathogen, some toxin, some who knows what, that has never been seen before in the history of the planet. You've synthesized it and you inject it

in a whole bunch of people. And they get totally sick and miserable. And then you come back two weeks later, two months later, and they will have made antibodies against that thing. Their body, their immune systems, will have made antibodies against some invasive pathogen

thingee that never existed before in the history of the planet. And a staggering challenge is how does the immune system come up with this vast variability for dealing with novel pathogens, making antibodies that will recognize them?

And people soon discovered one of the tricks was splicing of genes relevant to making antibodies and juggling them around-- induce-able, transposable events-- in the hope of making a gazillion new types of antibodies in a remarkable filtering process that goes on

in the immune system, spotting are any of them good against this new thing that just showed up? That's where you had a lot of transposable events in the vertebrate immune system in response to novel pathogens. Turns out, we weren't the only ones doing that because there were other things that

could be happening. There were all sorts of the pathogens that could do the same exact thing. There is one tropical parasite, Trypanosome, which is one you do not want to get. And trypanosomiasis is the inflammatory disease

you get from a trypanosome, this parasite, and it shows up in your body, and your body does this induce-able trick and, thank god, comes up with some antibodies that could begin to target it and attack it. But trypanosomes also worship at the altar

of Barbara McClintock. What they do is, a couple of weeks into it, they take away the surface proteins on their surface and they juggle some of the relevant DNA and come up with a novel version of it. So just as you've got the antibodies online,

you can't recognize the thing with those antibodies. You've got to start the process all over again. And thus trypanosomes are always a couple steps ahead, thus the immune system has to have evolved better ways of juggling, coming up with novel stuff. Co-evolutionary races there.

But the cornerstone of it is inducing movable genetic elements. And what people have learned since then is it occurs outside of just the immune system and under interesting circumstances. One really amazing one, which I was going to tell you later

but I will tell you now because I just can't wait-- there is one transposable element that's very predominant in primates. And there is a certain cell type and a certain time of life when it is most mobile, when it moves around the most-- which is, the cells in your brain that are going to be making

new neurons, neural progenitor cells, at the time that they start proliferating and making new neurons. There is an induce-able event at that time where you increase the movement of that one genetic element. What are you doing? You're making some new neurons.

And, as it turns out, in a fairly controlled realm of your DNA, you decide to shuffle the deck a little bit just because you want to get the interesting novel sort of things that neurons can do. This is totally amazing. This is totally amazing because, among other things, what

this tells you is the cells in your body that have the greatest thing to do with making you who you are, are the least constrained by genetic determinism. Because right when these types of cells, neurons, are first being generated, they're doing more shuffling of genetic cards

than any other cell type in the body. That sure takes away the power of genes a lot when it comes to the nervous system. These transposable events make a whole lot of variability, some of which is wonderful. Some of which is not, and this is coming back

to the question that was asked before, are these disastrous? In most of the cases, yes. But in a few minutes, we'll see exactly why it is not likely that when you randomly shuffle a bunch of cards, they're going to come out in a perfect sequence of numbers or some such thing.

It is a long shot to get something interesting out of it. Nonetheless, this is a mechanism for doing this. What this allows you to do by moving parts of DNA around, making a copy of this stretch and then moving it and, I think-- I don't know the field that well,

but I think, at least in most cases, the notion is it plunks down randomly somewhere else in the genome. By moving stuff around, you can have big macro consequences. For example, suppose you've got, by now, and if/then clause introducing this concept

already-- if/then clause, and we can translate this totally primitively into worlds of promoters and worlds of the actual gene. So you've got an if/then clause. Suppose you are dehydrated. If you were dehydrated, translating that

into actual biology, I don't know, your hematocrit or how wrinkly your kidneys are getting or some such thing. Then tell your kidneys to start doing something or other that kidneys do to retain water, which I once understood for a finale, no longer do. But you wake them up and they have some response.

So we've got an if/then clause. If you were getting dehydrated, then make your kidneys work in a way that increases water retention. This is ridiculous. There is if you are getting dehydrated promoter. There is no gene that is equivalent.

There's networks, though. There's networks, and there's ways in which your kidney monitors that and other outposts in your body. So we have a rough if/then clause. Wouldn't take a whole lot of imagination

to turn that into real biology. Now suppose you have some transposable events. Suppose whatever it is, the promoter world of that, picks up and moves and the if you were dehydrated part of the if/then clause floats around. It gets plunked down upstream from the genes

that say go and ovulate. What have you just invented? What does this allow you to do? So now you've got an if/then clause, a promoter of that response to dehydration, and it turns on genes related to ovulation.

What does that get for you? Any ideas? Oh, come on. Ovulate really frequently. Ovulate--

Really frequently. Really frequently. Depends on your threshold. If like you should be-- skip orange juice in the morning, does that mean you're dehydrated enough to ovulate. You could set it at a very low threshold like that.

You could do that. You could do something else though. What else? [INAUDIBLE] You're about to die of dehydration

and that gives you one last chance for a round of passing on copies of your genes, if you could find some guy who isn't dehydrated to dramatic blood flow extent. That's a possibility. What else can you do?

Seasonal mating. Yes, seasonal mating. That's what it's mostly used for. Certainly possibilities here. But what this allows you-- you're a species where six months of the year it's dry

and six months of the year it's wonderful wet and lush and exactly the time you want to be having a baby. And you've got like a six month gestational period. What do you want? You want your body to know when it's the dry season, and that's the signal to mate, because you want to give birth

during the rainy season. And then there's species where you are pregnant for two weeks or so. And what you want to have there as a rule is, oh my god, if it's the dry season, don't ovulate, because I'm going to give birth to kids who are going

to starve or some such thing. Let's wait until I get a signal that I'm totally wet and hydrated. Then ovulate. You introduce novel if/then clauses. And for certain species, this would

be how you would do seasonal mating-- how to know you should obviously at a time of year where, given your gestation length, it's going to set you up for giving birth at the time of year when your offspring are most likely to survive.

And thus, you will have passed on copies of your genes. All of that. So that's great. Another example. And this one is immediately accessible and is a first crude way of beginning

to approach some of this stuff that just flowed seamlessly and cheaply in the forms of theories from last week's stuff. So you have some if/then element in there and a promoter which, in some way, can tell this individual near me smells like me.

And we will see, by next week, exactly how that translates into genetics. But this individual kind of smells a lot like me. And it has an if/then clause which immediately shuts down transcription of all sorts of things related to fertility. You don't mate with relatives.

Some sort of incest taboo runs through a gazillion species out there. Individuals smelling like you, if you were a hamster, make you much less likely to mate with them. So a very logical if/then clause. All that works great.

And now you've had a transposable genetic event. And you plunk down the, if it smells like me then, into upstream of the gene that says cooperate. And what have we just invented? The starts of kin selection. And you could see all sorts of rules like,

if you have more promoters, you could begin to have subtleties of saying, if they really, really smell a lot like me, like if all these promoters are going off at once, then really, really, really cooperate. If they smell only somewhat like me, only somewhat cooperate. You could begin to fine tune that.

What have you just invented? A way of taking sensory information about degree of related-ness and turning that into your extent of sacrificing for one sibling or eight cousins. So you could begin to see how you invent new if/then clauses.

Obviously this is ridiculous. Obviously this bears no relationship to what's going on in the real world. This would be happening in nose cells. This is occurring down in the ovaries. There is no promoter that responds to, oh, somebody

here is smelling like me. But there are some that do stuff not all that far from that. You could begin to imagine turning this into real biology, how you could program for this. And once you've got genes moving around, you've plunked a promoter down someplace else.

You've just made a new if/then clause. Now the possibilities is of transposing genetic elements, also raises the possibility of moving around parts of genes-- not just parts of regulatory elements-- moving around parts of genes. How would you do that?

How would you move a part of a gene? Exons. That's that modular construction of genes again, where if you get a transposase that comes and does its thing there, and in making a copy of this, moves this stretch around,

you're now moving copies of parts of genes around. And you can relate new genes. For example, here we have the basic mechanism of action of steroid hormones. You guys who need an introduction to that, we'll get it in a week or two.

Steroid hormones-- hormones like estrogen, progesterone, testosterone, glucocorticoids. All of these, they work as follows. Steroid hormones can enter a target cell and they bind to their receptor. Yes, indeed.

Lock and key. All that happens. Steroid hormones are not made of amino acids. They have a different structure. But nonetheless, each has a distinctive shape. And each type of receptor for a type of steroid hormone

has a distinctive shape driven by its amino acid sequence and those gene codes. All of that. So you've got a specific type of steroid hormone fitting into its specific type of receptor-- estrogen into an estrogen receptor, that sort of thing.

And what it does as a result is it activates this receptor complex. And on the other side of it, is a confirmation which recognizes a particular promoter down on the DNA. A, in this case, what would be called an estrogen responsive promoter.

So what have you got there? You've got events going on in the outside world. You are reading the right parts of some novel and suddenly you're secreting certain hormones that weren't there before. And you're changing genomic effects shortly afterward.

This is environment regulating genes like crazy. What is this requiring? One part of the receptor recognizing the hormone, specifically. And one part of the receptor recognizing its specific appropriate promoter.

So now along comes one of those transposable events. And it happens, steroid hormones-- this would be called the hormone binding domain. And this would be called the DNA binding domain. In steroid receptor genes, those are in different exons. And suppose along comes a transposable event.

And you clip this part off and you stick it in a different hormone binding domain. So you've just made a completely different if/then clause. If this hormone is around, then do this. Now suddenly instead it's, if this hormone is around, then do this.

New if/then clause. Here would be one possibility. One of the class of steroid hormones, glucocorticoids, which eventually you will come to love because you will hear endlessly about it. And glucocorticoids, they're stress hormones.

Human version of hydrocortisone. For our purposes right now, what's interesting about them is they suppress the immune system. These are steroidal anti-inflammatories. When you're taking non-steroidals, you're taking things that work like glucocorticoids

on the immune system, but they don't have some of the side effects. Glucocorticoids suppress the immune system. It is very well understood. And glucocorticoids come in and bind to the hormone binding domain of the glucocorticoid receptor.

And this translocates to a glucocorticoid responsive promoter. That's its whole thing. So now you have gotten a transposable event. And what you've done instead is plunked down the hormone binding domain from the progesterone receptor.

So suddenly you've got an if/then clause that's novel, instead of, if they are glucocorticoids around, suppress immunity. Now instead you've got, if there's progesterone around, suppress immunity. What do you think you've just invented?

Any uses for that? If you happen to know what progesterone is about and where that might have been a great invention to come up with. Any speculation? During pregnancy? During pregnancy.

Progesterone, which is progestational-- so you suppress your immune system during pregnancy. How come? Why is that a clever thing to do? So your body doesn't eat your baby. [LAUGHTER]

Did you just say so your body doesn't eat your baby? [LAUGHTER] Well, there you go. I don't know what your family is like, but I won't speculate. [LAUGHTER] But, yeah.

You do that so your body won't eat your baby. So your body doesn't do that, so that you don't have an immune reaction against it. And that's a whole world of having to decide this thing belongs here, instead of this thing having invaded my placenta-- back

to that word that was used by gynecologists talking about last week-- the imprinted genes. Male derived imprinted genes making for a more potent invasion into the placenta. All of that. Yeah.

This is a great way to now do that deal of, you suppress immunity during pregnancy, you are less likely to have some weird immune attack on your fetus. And that was a great invention. That was a wonderful thing to have come up with.

There's an interesting consequence of that, though, one that pops up in medicine often, which is-- so you are immune suppressed because you're pregnant and then you give birth, and you stop being immune suppressed. The progesterone disappears for the most part.

You're off into a very different endocrine world at that point. Your immune system comes back to where it was before hand. But there is a potential problem, which is your immune system is so wiped out and you're so distracted changing diapers and having no sleep whatsoever, and so your immune system is

a little bit out of control. What if it recovers from this pregnancy immune suppression and, instead of coming back to where it was before, it overshoots a little bit? What have you gotten at that point?

Your immune system shoots into being more active than it should be at that point. What class of diseases are you set up for now? Autoimmune. Autoimmune disease. Whoa, that's as good as the lock and key,

everybody knowing that one. You are set up for an autoimmune disease then. There is a whole realm of autoimmune diseases that tend to have either initial onset or flare up in the post parturition period for women. And in fact, there are some autoimmune diseases,

a very serious form, say, of lupus, women really should not get pregnant, because they are going to get such a burst of lupus flare ups afterward. So this is a clever thing during pregnancy, as usual. You don't want to overdo it.

Our main point here though is, by doing some transposable event, moving one exon around and sticking it to another exon that never existed before, you've made up a completely novel if/then clause. So where have we gotten so far?

We are worlds away from the dull, gradualist world of micromutational stuff from the other day of one protein working differently. You have the capacity to invent completely novel proteins through splicing enzyme changes, through transposable events. You have the opportunity to make completely novel networks

with mutations and promoters, with mutations and transcription factors. What all of this means is, there is going to be major changes. And thus, after a five minute break, we will come back to your question there of, what are the odds of these changes actually

being good for you? So a five minute break. Sometimes you will find a gene will be duplicated. There will be an extra copy of the gene. There will be two copies, one after the other. Gene duplication.

Sometimes, you can have even a larger expansion of the number of copies of a gene. Or you can have duplication of a whole stretch of genes. And this is falling into this new area that people refer to, calling it copy number variant. And ranging from one extra copy of one gene

to massive duplication of whole stretches of chromosomes. And no surprise, you wind up getting interestingly different things going on at that point. What we'll see later on in the course is, there is more and more evidence that the disease schizophrenia involves mutations in copy number variance.

And here, this is not a mutation in one base pair. This is not a mutation in one transcription. This is extra copies of genes sitting there. This can have some very interesting implications. In some cases, the second gene can function as a backup. If something goes wrong in the first one,

there's a second one there doing its job. And there is some suggestion that something like that is occurring in some subsets of Alzheimer's disease. Or what you can have is the number of copies of the gene you make has something to do with how much of the protein you make.

And there's recent studies showing that when you compare Japanese populations with Western European ones, on the average, Japanese populations have more copies of a gene that has multiple copies, more copies of a gene that makes an enzyme related to carbohydrate digestion.

I have no idea what the implications would be of that. But this is not a populational difference in a DNA sequence or in a-- this is simply the number of copies of the gene. What a second copy, what a duplication also allows you to do in the most metaphorical sense is experiment with one of the copies.

Because the other one is there taking care of whatever the function is that's critical, what you'll see is you get faster evolution going on with genes that you have duplicated, where one of them is the one that, in a sense, is freed to have more dramatic movement.

And what you then see is it's more likely to stumble into some great use without sacrificing the initial use in the process. And there's a guy at the University of Oregon named Joe Thornton who's done really interesting work on the evolution of genes

for steroid receptors. And what he has shown from ancestral genes is that's exactly what's occurred. A lot of what are now two different genes for two different types of steroids receptors were once duplicates of the same gene.

And one was allowed to float and eventually, in at least some cases, stumbled into something useful, while the other one held into place. In passing, what that phenomenon does is help explain one of the endless, frustrating, exasperating, irritating things that people

who attack the notion of evolution bring up, which is the famed sound bite that they have of the problem irreducible complexity. It always runs the same way, which is saying that evolution can't possibly exist because is what good is half of an eye?

You've got to have those intermediate forms. And what good is it-- you couldn't have invented. Evolution could not have produced an eye in one mutation, one generation, and thus it would have to be in a series of steps. And what good are the series of steps?

They can't exist. There can't be anything such as evolution. Off you go. Hallelujah. So what you get here in these cases is a demonstration, instead, by having

extra copies of genes, one of which is freed to be evolving. You don't have to have a rapid transition from one to the other. You can have this thing moving along, stumbling along, until it just happens to come up with a shape of a receptor that just happens to be able to bind a hormone that stumbled

its own way into existence 10,000 generations earlier, which because it was duplicated, it didn't matter that one copy was now of a form where there was no receptor on earth for it until it happened to stumble into that. And there is more and more evidence that duplicated genes have a way of describing

these intermediate states where you don't necessarily have half an eye, but instead you have the pieces ready in place there for when one thing suddenly pops up, which completes the picture. In fact, you can have, as it turns out, sort of half.

Russ Fernald in the biology department has done really cool research on the evolution of eyes. And you should read about it some time to read basically how eyes evolved from a single layer of cells on the surface of some ancient proto something.

And you sure can have half an eye and a zillion intermediate forms. None the less, this business of multiple copies allowing you the freedom to have loser evolving of single genes of a time-- critical mechanism. So now we've got all of our pieces in place-- changes

in splicing enzymes and promoters and transcription factors and transportable elements and number of copies of genes, number of copies of whole stretches of genes. What wind up being the consequences of this? Back to the question brought up before.

So what we saw the other day is some time futz around with one single base pair, one single gene, and you've got somebody who's going to be dead at three months of age. PKU, phenylketonuria. One single gene could be a total, utter disaster.

My god. Instead now, thanks to these macro evolutionary changes, you change one single base pair and as a result you change-- one, two, three-- seven different genes. No, not seven. But you change more than one gene,

you have one single base pair change, and if it's an exon that's used in a lot of different combinatorial ways, you've now produced mutated versions of a whole bunch of different proteins. One single change in the transcription factor and you've

invented an entirely new network of expression. What are the odds of stumbling into something there that is going to suddenly be great and wonderful in all those different areas of consequence? It's really unlikely. What have we just seen here?

This is a very stabilizing mechanism for equilibrium. Equilibrium, long periods of stasis. What we've got is, if a single base pair change is going to affect half a dozen different proteins or affect, through a transcription factor, entire networks, the odds are pretty lousy that you are just

going to happen to stumble into one that works in all those domains, or at least works in enough of them that it doesn't do you in in others. Most of these macro mutational changes are going to be bad news. Most of the time, in other words,

there is stabilizing selection against macro mutational changes. So what have we just gotten? We've just gotten a straight line. We've just gotten long periods of stasis. So when do the changes come?

When you have some circumstance that is extreme enough that it doesn't matter that if this mutation-- you have made elevendy new types of proteins. And elevendy minus one of them are not great news. And the final one used to kill you. If the final one now is the trait that

is going to save you, it is going to carry the weight of all the other proteins that are changed. If you get what is called an evolutionary bottleneck, if you get a circumstance of such severe selection for such a tiny subset of traits, that basically the rule is

it doesn't matter-- if you have that trait-- it doesn't matter how much of a network you've changed, you're going to be one of the ones who come through and everybody else does not. And the evolutionary record is full of all sorts of circumstances where there have been selective bottlenecks

where 1% of a population comes out the other end of it because of some rare trait that they had which carries all the macro consequences of that. For example, there was clearly some sort of bottleneck of selection that went on with cheetahs about-- I don't know, a couple thousand years ago or so.

People have estimated more accurately. Because all the cheetahs are so genetically similar to each other that you can transplant tissue, you can graft tissue from any cheetah on earth onto another one and there will not be rejection. All of the cheetah on earth are closely related descendants

of what had to have been fairly recently, a couple of thousand, a tidy, remnant population that now is highly inbred and you had some sort of selective bottleneck that went on at that time. Similarly, I can't remember when in hominid history, but the suggestion was at at least a couple of points

in hominid evolution, there have been points of selective bottlenecks where glaciers or comets or knows what, where only a small subset of individuals with some traits that have been, up until then, neutral or are unlikely to be useful because of these big macro consequences, suddenly only the folks who had it

came out the other end. What are we beginning to describe here? Circumstances of rapid change. Circumstances of punctuated radical change. There are circumstances that begin to make conceivable punctuated equilibrium.

It's so intrinsic in this huge complexity of macroevolutionary change in DNA because of the structure intrinsic in it are two critical things. One is the vast majority of the time, make a change which changes some whole network and it's going, to be a disaster.

The majority of the time, there's going to be stasis. And also intrinsic in that is the ability to have massive macro changes, any of these examples we've had here, where, in periods of selective bottlenecks, you're going to get something like that happening.

So Gould and friends are absolutely right. All of that. Not necessarily. Because again, this radical rapid change period, that's for paleontologists, for biologists. That's thousands of generations, in some cases.

Again, what counts as very rapid in one scientific discipline may not be the same for the biologist at the other end. Nonetheless, this winds up being a mechanism for long periods of spaces and very rapid change. So that suggests that, where we have these mechanisms.

So how does one begin to resolve the microevolutionary picture of gradualist social biology from last week and the macro picture of punctuated equilibrium drama, all of that? How do you begin to put the pieces together? A number of ways that it could be done.

Let me just see here. Yes. A number of ways it could be done. One is thinking again about micro mutational changes or about changes in the function of preexisting proteins. And macro mutational changes are about the invention

of new proteins, new networks, new, if/then clauses, all of that serving different functions. Back to the difference in the genome between humans and chimps. When you look at the micro versus the macro differences, for example, in the domain of the immune system,

most of the differences between humans and chimps genetically have to do with microevolutionary differences. And that comes down to clinical pictures that you see humans are much more resistant to tuberculosis than chimps are. Chimps are much more resistant to malaria than humans are.

Nonetheless, it's the basic nuts and bolts of the immune system there. One of these guys has a little bit better of this, one has worse of that. This is within a realm of gradualist change. The genetic differences that explain that

are microevolutionary ones. Where are the macro evolutionary differences between humans and chimp genomes? Those are the ones that have to do with development. And those are the ones that amplify differences big time. You have one tiny little difference and you

get an organism that's going to look as different from a chimp as a human does. The other way around, some systems, their evolution is much more built driven by micro changes, some much more than macro. Some of the most interesting macro stuff

is going to be developmental blueprints, developmental trajectories. What else? What else in terms of resolution? There are plenty of fossil histories by now for some line that are complete enough that it is

very clear they look like this. And the majority of fossil pedigrees that are that detailed enough support a punctuated model. Nonetheless, there are plenty that are understood with as many time points in here that follow gradualist models.

So evidence for both. Nonetheless mostly punctuated evidence. The biggest problem though in debating all of this is it is impossible for the most part to see gradualism going on, because it's gradual, because it's hard to spot that.

It's hard to show whether changes are incremental or changes are rapid. But by now, there are a few examples where people have actually been able to observe evolutionary changes in organisms and ones that can count as fairly rapid.

One first example-- for reasons I cannot begin to understand, people in Chicago-- I don't know if it's in the Chicago Field Museum or the mayor's office or something-- have all sorts of carcasses around from rats killed in Chicago in the 1880s. Key to the city, souvenirs, who knows what?

Chicago's centennial. But those around stored someplace. And a few years ago, researchers were able to look at the genomes of those beasts compared to rats that are being taken these days off the streets of Chicago, current ones,

and showing over the course of a century, a lot of the genome has evolved. There are a lot of differences. Over the course of a century-- I don't know, what is that? Maybe 500, 1,000 generations or so. There has been significant change over that time.

Darwin's finches, for those of you Darwin history fans, that started the whole thing. All sorts of different species. The finches found in the Galapagos Islands and people have been studying them for half a century, three-quarters of a century.

Gene distributions are changing-- gene distributions for traits, like the size of your bill and thus what kind of food you could break into, in response to environmental shifting there. That is being documented. That's going on.

What else? Another one that is really interesting and important and critical for lots of us, which is the evolution of resistance to diabetes. This is a very interesting phenomenon. Diabetes comes in two forms.

Juvenile onset diabetes-- that's the one where you need insulin. The diabetes that's instead becoming an epidemic is adult onset diabetes, which is when you have a body which is all built out of lean hominid history to store away lots of calories and all of that, and you throw in a westernized diet

and you get the increasing westernized problem of obesity. And you then wind up getting diabetes. For our purposes right now, it doesn't matter what diabetes looks like. The main thing is, it is driven by food excesses in westernized diets.

So there's been a whole literature by now of people studying populations that have had rapid shifts from traditional diets to westernized diets. A lot of Pacific Islanders have been studied. All sorts of other populations.

The group that is the iconic one to study is Native American group in Arizona called the Pima Indians. And what's very convenient about them is about half of them live in the United States and about half in Mexico.

And there has been very rapid changes in diet in the American side, less so in the Mexican one-- far more traditional. And one of the things that soon emerged once westernized sort of typical processed food became the predominant food eaten by people in the Arizona

side is 90% diabetes rates by the time you're 30 years old. The exact same thing in some of the Pacific Islands that have been studied, in the Naru and Samoa and some of these other places. Astronomically high rates of diabetes. Another population where it's been studied

are populations of Jews who were living in Yemen and who-- I think in the '60s or '70s-- moved to Israel, switching from a very traditional diet to a very westernized one. Diabetes rates absolutely through the roof. What that's doing very quickly was killing off

all sorts of folks very early in their reproductive life history periods. Suddenly you've got the people who are most vulnerable to diabetes when suddenly given a westernized diet, they're leaving fewer copies of their genes.

And it's been in the last decade or so, some of the Pacific island populations that have been studied, the diabetes rates are beginning to go down. In other words, there has been this selection that went into Western European populations,

I don't know, a century or so, which is the folks who have the most efficient metabolisms and can store away all of those dozens of Hershey bars effortlessly. They're dead. And they died before they left copies of their genes.

You are now selecting for human populations that have sloppier metabolisms. And this is within the course of a century. Another example. Here's a totally, totally cool, irresistible one. This is one of the great genetics stories.

As you can see, or not, this pure white screen tells you that this is research that went on in Siberia. [LAUGHTER] Actually, these were Siberian-- so this was a famous study done by this Soviet geneticists starting,

I don't know, about 50 years or so, where you have these Siberian silver foxes. And that's what they look like. And for all sorts of reasons, who knows what, it is highly valued to have clothing made out of their bodies, and thus highly valuable wild animals,

tough to get. And this guy decided, well, what we need to do is start some Siberian silver fox domestication farming stuff. So he did a very logical thing. He started selectively breeding them for tameness.

He would have a bunch of captive foxes that were wild born and most of them totally feral and crazed. And he would see, is there a subset, 5%, 10% of them, that I could get relatively closer to that were calmer in the human's proximity? Only let those ones breed.

Now take their offspring and only take the 10% or so that are most calm, most easily tamed. And it took about 35 generations or so to get foxes that were as tame as dogs are. Something else totally amazing. So he's breeding them for only one trait-- a behavioral trait,

which is the ability to get close to them if you're a human, calmness on their part, whatever you might describe it as. Breeding entirely based on that trait. And when you spend 35 generations breeding a wild animal like a fox so that it's

the ones who are most able to function in the role of domesticated animals, it's not just the behavior that changes. This is what the adults look like 35 generations later. Aw! [LAUGHTER]

Oh, give me one. Give me 100. I want-- yes. They're adorable. Can you believe how great they look? What's going on here?

They were selecting for a behavioral trait, and they are fox puppies. They've got a big roundy ears and these cute little short muzzle things. And they wag their tails when humans show up. And these are not dog descent into wolves.

This was 35 generations to turn something on to left into something looking at the right. Very interesting thing we will come to in the ethology lectures. Basically, what you're breeding for when you're breeding a wild animal to be tame-able,

your breeding for the ones that behave more childishly, the ones who are acting more like developing animals who are more dependent on other individuals. You're breeding them for infantile traits. This is what a baby fox looks like.

This is what these domesticated foxes look like. Totally amazing that this happened. Ironic ending department-- you will notice that the coat has changed from the ones on the left to these wonderful coats that you just want to have made into underwear and hats and all

of that sort of thing. And on the right, they look like Spot and Rover and all those guys. It is called a piebald coloration pattern. Somehow also, you can't get the domestication without that happening.

Ironic ending-- nobody wants to wear clothes that look like that. They would've been killing Dalmatians for years if that were desirable. In the process of breeding them, they became useless economically.

Nonetheless, totally amazing demonstration. 35 generations and you turn something on to left into something looking like that on the right, who will wag its tail like you would lick your face and bring your chewed up slippers back to you. This is a very rapid change.

Final example. This is one that is also quite consequential, and one possibly even more so than diabetes, which is if this type of evolution keeps occurring at the rate that it's happening, all of us are going to have dramatically shortened life

expectancies-- antibiotic resistance in various bacteria. Evolution going on there. What we see in all sorts of cases is, evolution is not just occurring over the course of glacial lengths of time. It can be occurring very rapidly.

And what we see here also is, in some cases, it's going to leave a different sort of skeleton, changing how good your kidneys and pancreases are dealing with westernized food, that's not going to make for a different fossil. Breeding for antibiotic resistance in bacteria

is not going to make for a different-- actually, can bacteria even make fossils? Does anybody know? Yes. Yes. So it's going to make bacterial fossils that look exactly--

all of this interesting amazing stuff going on, and it's stuff that no punctuated radical dogmatic paleontology type would ever be able to pick up. So what are we heading to here? We're heading to a wonderful heart-warming resolution of these different schools of thought, which

is, can't we all get along? And can't we all have means of having different types of evolution happening? So almost certainly harking back to what mentioned before, microevolutionary changes-- the immune system in chimps versus humans.

Macroevolutionary changes development. You don't have to choose vanilla or chocolate. They could be going on at the same time. And they could be going on at the same time in a very important resolving way, which is-- so you've got evidence for a punctuated change

of some trait. And single traits don't evolve at a time. They come in whole packages, packages making you wag your tail and such. So there is some other punctuated thing going on. And that's its pattern happening there.

And then meanwhile, you've got some other trait moving, evolving in a punctuated manner. I guess it doesn't go down. And you put enough of these together and have enough punctuated events happening, and on a whole population level, you've

just invented gradualism. You don't have to choose. You can have it all. You can have it all. So a resolution there. Both are almost certainly happening.

So what does this set us up for now? Now that we have finished this bucket, we are now ready on Friday-- what is today? Wednesday. We are now ready on Friday to move to the next bucket, which is a very different world of trying to make sense

of the genetics of behavior. Last week's version, you make up stories built around individual selection, kin selection, group selection, and come up with the best story around to show me something more predictive.

And you win. This week's version, showing actual genetic changes over the course of time. What patterns of evolutionary change will those code for with what consequences for understanding the evolution of behavior, competition,

reproductive strategies, all of that? By the end of this week, switching over instead to the world of behavior geneticists, where they try to understand what's going on by looking at-- so somebody gets adopted. Do they share a trait more with their adoptive parents

or their biological parents? You look at identical twins versus non-identical ones. You look at identical twins who were adopted into different families right at birth, put them back together. A whole world of trying to make sense that way. And what we'll see is the same deal

is with this-- what counts as finishing, coming up with an explanation-- last week's social biology approaches-- this version of this is the starting point for the next discipline. So we'll pick up on that on Friday. Oh, my god.

He let us out-- For more, please visit us at stanford.edu.



Video Description

(April 7, 2010) Robert Sapolsky continues his series on molecular genetics in which he discusses domains of mutation and various components of natural selection on a molecular level. He also further assesses gradualism and punctuated equilibrium models of evolution, integrating these theories into an interrelated model of development.


Stanford University
http://www.stanford.edu

Stanford Department of Biology
http://biology.stanford.edu/

Stanford University Channel on YouTube
http://www.youtube.com/stanford